Literature DB >> 25207008

Clinical and predictive significance of hyponatremia after aneurysmal subarachnoid hemorrhage.

Vladimir Vrsajkov1, Gordana Javanović1, Snežana Stanisavljević1, Arsen Uvelin2, Jelena Panti Vrsajkov3.   

Abstract

OBJECTIVE: Hyponatremia after SAH was the object of several studies with conflicting results. The aim of this study was to determine a predictive correlation of hyponatremia with delayed cerebral ischemia (DCI) and poor clinical outcome.
MATERIAL AND METHODS: We have used a retrospective hospital chart review of 82 patients with SAH treated from August 2008 to August 2010. Patients were divided into hyponatremia and normonatremia groups. Hyponatremia was defined as serum sodium level <135 mmol/l. Information compared and analyzed included demographics, preoperative neurological status, aneurysm characteristics, postoperative intensive care, duration of stay, DCI and clinical outcome at hospital discharge. P<0.05 was considered significant.
RESULTS: Thirty-two patients with SAH (39%) developed hyponatremia. In that group we had a significantly higher WFNS score at admission (p=0.03) and longer duration of stay in intensive care (p=0.001). DCI with transit or definitive deficit included 20 patients (62%) in the hyponatremia group, and 19 patients (38%) in the normonatremia group (p=0.03). Binary enter logistic regression revealed a significant correlation of hyponatremia with DCI (p=0.03) and poor clinical outcome (p=0.001).
CONCLUSION: This result revealed a possible use of hyponatremia as an additional predictor of developing DCI and poor clinical outcome.

Entities:  

Keywords:  Glasgow outcome scale; Hyponatremia; cerebral ischemia; subarachnoid hemorrhage

Year:  2012        PMID: 25207008      PMCID: PMC4115839          DOI: 10.5152/balkanmedj.2012.037

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  19 in total

1.  Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage.

Authors:  E Berendes; M Walter; P Cullen; T Prien; H Van Aken; J Horsthemke; M Schulte; K von Wild; R Scherer
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

2.  Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage.

Authors:  Adnan I Qureshi; M Fareed K Suri; Gene Y Sung; Robert N Straw; Abutaher M Yahia; Mustafa Saad; Lee R Guterman; L Nelson Hopkins
Journal:  Neurosurgery       Date:  2002-04       Impact factor: 4.654

3.  High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms.

Authors:  T Sayama; T Inamura; T Matsushima; S Inoha; T Inoue; M Fukui
Journal:  Neurol Res       Date:  2000-03       Impact factor: 2.448

4.  A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients.

Authors:  B Zheng; Y Qiu; H Jin; L Wang; X Chen; C Shi; S Zhao
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-28       Impact factor: 10.154

5.  Plasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage.

Authors:  M Tomida; M Muraki; K Uemura; K Yamasaki
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

6.  Critical care management of subarachnoid hemorrhage.

Authors:  Joshua M Levine
Journal:  Curr Treat Options Neurol       Date:  2009-03       Impact factor: 3.598

7.  Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage.

Authors:  E Isotani; R Suzuki; K Tomita; M Hokari; S Monma; F Marumo; K Hirakawa
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

8.  The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage.

Authors:  Mark Sherlock; Eoin O'Sullivan; Amar Agha; Lucy Ann Behan; Danny Rawluk; Paul Brennan; William Tormey; Christopher J Thompson
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

9.  Cerebrospinal fluid adrenomedullin concentration correlates with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage.

Authors:  Yoshitaka Kubo; Kuniaki Ogasawara; Shunsuke Kakino; Hiroshi Kashimura; Kenji Yoshida; Akira Ogawa
Journal:  Cerebrovasc Dis       Date:  2008-01-23       Impact factor: 2.762

10.  A pilot study of dendroaspis natriuretic peptide in aneurysmal subarachnoid hemorrhage.

Authors:  Vini G Khurana; Eelco F M Wijdicks; Denise M Heublein; Robyn L McClelland; Fredric B Meyer; David G Piepgras; John C Burnett
Journal:  Neurosurgery       Date:  2004-07       Impact factor: 4.654

View more
  3 in total

1.  Sodium Variability and Probability of Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Melissa M J Chua; Alejandro Enríquez-Marulanda; Santiago Gomez-Paz; Yosuke Akamatsu; Mohamed M Salem; Georgios A Maragkos; Luis C Ascanio; Khalid A Hanafy; Corey R Fehnel; Christopher S Ogilvy; Justin Moore; Ajith J Thomas
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-11-05       Impact factor: 2.136

2.  Characterizing Risk of In-Hospital Mortality Following Subarachnoid Hemorrhage Using Machine Learning: A Retrospective Study.

Authors:  Jiewen Deng; Zhaohui He
Journal:  Front Surg       Date:  2022-06-08

3.  Genome-wide blood DNA methylation analysis in patients with delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Bong Jun Kim; Youngmi Kim; Dong Hyuk Youn; Jeong Jin Park; Jong Kook Rhim; Heung Cheol Kim; Keunsoo Kang; Jin Pyeong Jeon
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.